Introduction
Corynebacterium glutamicum is a gram-positive and nonpathogenic bacterium that is widely used for the industrial production of amino acids, such as L-glutamate and L-lysine [5, 7] . The complete genome sequence of C. glutamicum provides a large amount of information on its metabolic pathways and leads to the increased productivity [4, 6] . LLysine is synthesized from L-aspartate in multiple steps. Aspartokinase catalyzes the phosphorylation of L-aspartate into L-aspartyl-phosphate, with the subsequent conversion of L-aspartyl-phosphate to L-aspartate-semialdehyde (ASA) by aspartate-semialdehyde dehydrogenase. These steps are common to the biosynthesis of lysine, threonine, isoleucine, and methionine. The condensation between ASA and pyruvate, catalyzed by dihydrodipicolinate synthase, produces dihydrodipicolinate (DHDP), which is then reduced to tetrahydrodipicolinate (THDP) with the cofactor NAD(P)H by DHDP reductase. At this point, four different pathways are available [15] . Most bacterial species convert THDP to meso-diaminopimelate (meso-DAP) through the succinylase pathway, which includes four enzymes. Some Bacillus species utilize the acetylase pathway and dehydrogenase pathway to directly form meso-DAP, the precursor of lysine and an essential component of peptidoglycan in bacterial cell walls [14] . The aminotransferase pathway was recently identified [11] . In a few organisms, such as C. glutamicum and Escherichia coli, two lysine biosynthetic pathways are present. Finally, meso-DAP decarboxylase catalyzes the conversion of meso-DAP to Llysine [17, 20] .
Dihydrodipicolinate reductase (DapB; E.C. 1.17.1.8) catalyzes the reduction of DHDP to THDP and uses NADH or NADPH as a cofactor (Fig. 1A) . The cofactor binds to Rossmann folds comprising a series of alternating β-strands and α-helices. Sequence comparison of various NAD(P)H-dependent enzymes revealed that the nucleotide binding motif is very similar and contains the highly conserved sequence G-x-x-G-x-x-G [16] . Typically, the pyridine nucleotide-dependent enzymes prefer one of the two cofactors and show a dual-cofactor specificity, but utilize NADPH over NADH [9] . The preference for NADH or NADPH is correlated to the residues involved in stabilization of the adenosyl ribose ring. For NADH, glutamate and aspartate residues stabilize the adenosyl ribose hydroxyl group and NADPH-dependent enzymes have positively charged residues, such as arginine and lysine, which interact with the 2'-phosphate monoester [8, 18] . The enzymes exhibiting dual specificity have both acidic and basic residues in the adenosyl ribose-binding pocket. DapB from Mycobacterium tuberculosis utilizes dual cofactors and shows a greater preference for NADH [2] .
Compared with M. tuberculosis DapB, we hypothesized the cofactor specificity of CgDapB. Here, we present the crystal structure of DapB from C. glutamicum (CgDapB) in the apoform and in complex with its cofactor NADP + . We also report the cofactor specificity of CgDapB and domain movement upon cofactor and substrate binding.
Materials and Methods

Preparation of CgDapB
The forward and reverse primers had the following sequences: 5'-GCGCGCATATGGGAATCAAGGTTGGCGTTC-3' and 5'-GCGCGCTCGAGTTACAGGCCTAGGTAATGC-3' to introduce NdeI and XhoI restriction sites, respectively. The CgDapB coding gene (Met1-Leu248, MW 29 kDa) was amplified by polymerase chain reaction (PCR) using C. glutamicum chromosomal DNA as a template. The PCR product was then subcloned into pET30a (Life Science Research) with 6-histag at the C-terminus. The expression construct was transformed into an Escherichia coli B834 strain, which was grown in 1 L of LB medium containing kanamycin (50 mg/ml) at 37°C. After induction via the addition of 1.0 mM IPTG, the culture medium was further maintained for 20 h at 18°C. The culture was harvested by centrifugation at 5,000 ×g at 4°C. The cell pellet was resuspended in buffer A (40 mM Tris-HCl at pH 8.0 and 5 mM BME) and then disrupted by ultrasonication. The cell debris was removed by centrifugation at 11,000 ×g for 40 min, and lysate was bound to Ni-NTA agarose (Qiagen). After washing with buffer A containing 30 mM imidazole, the bound proteins were eluted with 300 mM imidazole in buffer A. A trace amount of contamination was removed by applying HiLoad 26/ 60 Superdex 200 prep grade (GE Healthcare) size-exclusion chromatography. The purified protein showed ~97% purity on SDS-PAGE, and was concentrated to 60 mg/ml in 40 mM TrisHCl, pH 8.0, 1 mM dithiothreitol.
Crystallization and X-Ray Crystallographic Analysis of CgDapB
Crystallization of the purified CgDapB protein was initially performed with commercially available sparse-matrix screens from RIGAKU and Molecular Dimensions using the hanging-drop vapor-diffusion method at 20°C. Each experiment consisted of mixing 1.0 µl of protein solution (90 mg/ml in 40 mM Tris-HCl, pH 8.0) with 1.0 µl of reservoir solution and then equilibrating against 50 µl of reservoir solution. CgDapB crystals were observed from several crystallization screening conditions. After several steps that improved the crystallization process using the hangingdrop vapor-diffusion method, crystals of the best quality appeared in 2.0 M ammonium sulfate, 5% 2-propanol. The crystals were transferred to cryoprotectant solution containing 2.0 M ammonium sulfate, 5% 2-propanol, and 30% (v/v) glycerol, finished out with a loop larger than the crystals and flash-frozen by immersion in liquid nitrogen. The data were collected to a resolution of 2.5 Å at 7A beamline of the Pohang Accelerator Laboratory (PAL, Pohang, Korea), using a Quantum 270 CCD detector (ADSC, USA). All data were indexed, integrated, and scaled together using the HKL2000 software package [13] . The crystals of CgDapB apo-form belonged to the space group I4 1 22 with unit cell parameters a = b = 107.39 Å, c = 175.67 Å. Assuming two molecules of CgDapB in an asymmetric unit, the crystal volume per unit of protein mass was 2.18 Å 3 Da -1
, which means the solvent content was approximately 43.69% [10] . , which corresponds to a solvent content of approximately 43.12%.
Structure Determination of CgDapB
The structure of apo-form of CgDapB was determined by molecular replacement with the CCP4 version of MOLREP [19] , using the structure of DapB from Mycobacterium tuberculosis (PDB code 1YL5) as a search model. Further model building was performed manually using the program WinCoot [3] , and refinement was performed with CCP4 refmac5 [12] and CNS [1] . The structure of CgDapB in complex with NADP + was solved by molecular replacement using the crystal structure of the apo-form of CgDapB. The data statistics are summarized in Table 1 . The refined model of the apo-form of CgDapB and that in complex with NADP + will be deposited in the Protein Data Bank with PDB codes of 5EER and 5EES, respectively.
Results and Discussion
Overall Structure of CgDapB To determine the molecular mechanism of dihydrodipicolinate reductase from C. glutamicum (CgDapB), we purified, crystallized, and determined the crystal structure of the enzyme at 2.5 Å resolution (Fig. 1B) . The crystal belonged to the I4 1 22 space group, and the asymmetric unit of the crystal contained two CgDapB molecules. The overall structure of CgDapB was homologous to that of dihydrodipicolinate reductase from Mycobacterium tuberculosis (MtDHPR), and the amino acid sequence identity between CgDapB and MtDHPR was 61% (Fig. 2A) . The CgDapB monomer consists of two distinct domains, the N-terminal domain (NTD) and the C-terminal domain (CTD). The NTD (Met1-Phe107 and Asn219-Leu248) comprises seven parallel β-strands (β1-β6 and β12) and six α-helices (α1-α5 and α8) and is mainly involved in the binding of the NAD(P)H cofactor. The center of the NTD contains a 7-stranded β-sheet, with six α-helices covering both sides of the sheet. The CTD (Ala108-Arg218) comprises five β-strands (β7-β11) and two α-helices (α6 and α7). The five β-strands form an anti-parallel β-sheet and the two α-helices are located on the NTD side covering one side of the β-sheet (Fig. 2B) . The domain constitutes the substrate binding site, which will be described later.
The CgDapB tetramer was generated by crystallographic symmetry operation, and the results of size-exclusion chromatography confirmed that CgDapB functions as a tetramer (data not shown). The tetramer is exclusively constituted by interactions between the CTDs. First, to The numbers in parentheses are statistics from the highest resolution shell.
R sym = Σ |I obs -I avg | / I obs , where I obs is the observed intensity of individual reflection and I avg is the average over symmetry equivalents. form a dimer, five β-strands from Mol I interact with those from Mol II, forming a 10-stranded β-sheet, and four α-helices (two from each monomer) covering one side of the β-sheet. The tetramer is then formed by interaction between the two dimers, where the two 10-stranded β-sheets of two dimers form a flattened 20-stranded β-barrel by face-to-face pairing (Fig. 2C) .
NADP + Binding Mode of CgDapB
To identify the NADP + binding mode, we determined the crystal structure of CgDapB in complex with the NADP + cofactor at 2.12 Å resolution. When we superimposed the NADP + -bound form of CgDapB with the apo-form of the enzyme, regional structural changes were observed, although overall the two structures were nearly identical. In particular, three connecting loops (β1-α1, β2-α2, and β3-α3) underwent structural transformations to stabilize the NADP + molecule with a maximum distance of 3 Å (Fig. 3A) .
The NADP + binding site was located at the G-x-x-G-x-x-G nucleotide binding motif, comprising residues Gly9-Ala10-Lys11-Gly12-Arg13-Val14-Gly15, and the hydroxyl groups of a pyrophosphate moiety were hydrogen-bonded with the main-chain nitrogen atoms of Arg13 and Val14. The pyrophosphate moiety was also stabilized by the side chain (Fig. 3B) . Interestingly, the phosphate group attached to the adenosine nucleotide did not interact with the neighboring residues. Moreover, we did not observe an electron density map of the phosphate group region, indicating that the phosphate group might be highly flexible in the bound form to the enzyme (Fig. 3C) . Since MtDHPR utilizes both NADH and NADPH as cofactors, we speculate that CgDapB utilizes both molecules as cofactors as well.
Substrate Binding Mode of CgDapB
We could not determine the CgDapB structure in complex with the dihydrodipicolinate substrate; however, we can infer the substrate binding mode of the enzyme from the MtDHPR structure in complex with 2,6-pyridinedicarboxylate (2,6-PDC), a competitive inhibitor of DHPR. In MtDHPR, the substrate binding site is located in the CTD; the aromatic ring of 2,6-PDC is stacked against the nicotinamide ring of bound NADP + cofactor, and two carboxyl groups form hydrogen bonds with neighboring residues such as His133, Lys136, and Thr143. Among these residues, Lys136 is thought to be a catalytic residue. Interestingly, in our CgDapB structure in complex with NADP + , we observed two sulfate molecules at the substrate binding site (Fig. 4A ). When we superimposed the CgDapB structure in complex with NADP + with the MtDHPR structure in complex with 2,6-PDC, the sulfate molecules were found to be located at positions similar to the two carboxyl groups of 2,6-PDC (Fig. 4B) . Moreover, the sulfate molecules in CgDapB were stabilized in a manner similar to the carboxyl groups of 2,6-PDC in MtDHPR. Sulfate I was coordinated through hydrogen bonding with the side chains of Lys138 and Thr145 and the main chains of Gly144 and Thr145. Additionally, sulfate II was stabilized by residues His135 and Lys138 through hydrogen-bond interactions (Fig. 4B) . Based on these observations, we propose that CgDapB shares both the catalytic mechanism and substrate binding mode with MtDHPR. Our study provides structural insight into the molecular mechanism of CgDapB, one of the key enzymes in lysine biosynthesis in C. glutamicum. Through the CgDapB structure in complex with NADP + cofactor, we determined how the enzyme utilizes both NADH and NADPH as cofactors. We also determined the substrate binding mode of the enzyme through the coordination mode of two sulfate molecules in our structure. Finally, we propose that the cofactor binds to the enzyme prior to substrate for enzyme catalysis, and domain movement to the active conformation requires binding of both the cofactor and the substrate.
